Dr. Theresa Werner, MD
Claim this profileHuntsman Cancer Institute/University of Utah
Area of expertise
Ovarian Cancer
Theresa Werner, MD has run 7 trials for Ovarian Cancer. Some of their research focus areas include:
Endometrial Cancer
Theresa Werner, MD has run 4 trials for Endometrial Cancer. Some of their research focus areas include:
Affiliated Hospitals
Huntsman Cancer Institute/University Of Utah
University Of Utah Huntsman Cancer Institute
Clinical Trials Theresa Werner, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting
1 award
Phase 2
10 criteria
Herceptin Hylecta or Phesgo + Chemotherapy
for Uterine Cancer
This phase III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin Hylecta \[TM\]) or pertuzumab, trastuzumab and hyaluronidase-zzxf (Phesgo \[TM\]) to the usual chemotherapy (paclitaxel and carboplatin) works to shrink tumors in patients with HER2 positive endometrial cancer. Trastuzumab and pertuzumab are monoclonal antibodies and forms of targeted therapy that attach to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When trastuzumab or pertuzumab attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Hyaluronidase is an endoglycosidase. It helps to keep pertuzumab and trastuzumab in the body longer, so that these medications will have a greater effect. Hyaluronidase also allows trastuzumab and trastuzumab/pertuzumab to be given by injection under the skin and shortens their administration time compared to trastuzumab or pertuzumab alone. Paclitaxel is a taxane and in a class of medications called antimicrotubule agents. It stops tumor cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Giving Herceptin Hylecta or Phesgo in combination with paclitaxel and carboplatin may shrink the tumor and prevent the cancer from coming back in patients with HER2 positive endometrial cancer.
Recruiting
2 awards
Phase 3
More about Theresa Werner, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Theresa Werner, MD has experience with
- Carboplatin
- Letrozole
- Paclitaxel
- Belinostat
- Ribociclib
- Upifitamab Rilsodotin
Breakdown of trials Theresa Werner, MD has run
Ovarian Cancer
Endometrial Cancer
Endometrial Adenocarcinoma
Ovarian Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Theresa Werner, MD specialize in?
Theresa Werner, MD focuses on Ovarian Cancer and Endometrial Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage III.
Is Theresa Werner, MD currently recruiting for clinical trials?
Yes, Theresa Werner, MD is currently recruiting for 5 clinical trials in Salt Lake City Utah. If you're interested in participating, you should apply.
Are there any treatments that Theresa Werner, MD has studied deeply?
Yes, Theresa Werner, MD has studied treatments such as Carboplatin, Letrozole, Paclitaxel.
What is the best way to schedule an appointment with Theresa Werner, MD?
Apply for one of the trials that Theresa Werner, MD is conducting.
What is the office address of Theresa Werner, MD?
The office of Theresa Werner, MD is located at: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah 84112 United States. This is the address for their practice at the Huntsman Cancer Institute/University of Utah.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.